Literature DB >> 15665538

Delayed diagnosis and lower resection rate of adenocarcinoma of the distal duodenum.

D Stell1, D Mayer, D Mirza, J Buckels.   

Abstract

BACKGROUND: Carcinoma of the duodenum is a rare disease that can present with varied symptoms and is often misdiagnosed. Prolonged survival following resection of the primary tumour is possible, whilst irresectable disease has a very poor prognosis. The factors determining resectability of the primary tumour have not been addressed. AIMS: We reviewed 45 consecutive cases of duodenal carcinoma to investigate factors which influence the operative outcome of patients with this condition. PATIENTS AND METHODS: Details of symptoms, diagnoses, surgical procedures and pathology were retrieved from patient records. There were 29 male and 16 female patients aged 24-79 years (median = 64 years).
RESULTS: The frequency of tumours in the proximal and distal duodenum was 27 and 18. Failure to diagnose the tumours at endoscopy occurred in 10 of 27 tumours of the proximal duodenum and 15 of 18 tumours of the distal duodenum. The duration of symptoms prior to diagnosis was correspondingly longer for tumours in the distal duodenum (20 weeks) than the proximal duodenum (12 weeks). Of 27 patients with tumours in the proximal duodenum, 18 underwent a potentially curative resection, whereas only 6 of the 18 tumours in the distal duodenum were resectable with curative intent. The reasons for irresectability of lesions in the distal duodenum included malignant lymphadenopathy affecting the small bowel mesentery in ten cases, which was not noted in any patient with adenocarcinoma of the proximal duodenum.
CONCLUSIONS: Our results suggest that lesions of the distal duodenum are inadequately investigated by endoscopy, and that distal duodenal tumours are less curable by resectional surgery due to invasion of the small bowel mesentery. Copyright 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15665538     DOI: 10.1159/000083470

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  11 in total

1.  Remission of primary duodenal adenocarcinoma with liver metastases with S-1 chemotherapy.

Authors:  Yoshiki Katakura; Michihiro Suzuki; Mika Kobayashi; Kazunari Nakahara; Nobuyuki Matsumoto; Fumio Itoh
Journal:  Dig Dis Sci       Date:  2007-01-17       Impact factor: 3.199

2.  The surgical treatment and outcome for primary duodenal adenocarcinoma.

Authors:  Shao-Liang Han; Jun Cheng; Hong-Zhong Zhou; Qi-Qiang Zeng; Sheng-Hong Lan
Journal:  J Gastrointest Cancer       Date:  2010-12

3.  Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma.

Authors:  Giuseppe Malleo; Alfredo Tonsi; Giovanni Marchegiani; Andrea Casarotto; Salvatore Paiella; Giovanni Butturini; Roberto Salvia; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2012-07-17       Impact factor: 3.445

4.  Clinical and endoscopic findings to assist the early detection of duodenal adenoma and adenocarcinoma.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Masayuki Shimoda; Hideki Mori; Seiichiro Fukuhara; Sawako Miyoshi; Tatsuhiro Masaoka; Yasushi Iwao; Yae Kanai; Takanori Kanai
Journal:  United European Gastroenterol J       Date:  2018-12-03       Impact factor: 4.623

5.  15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.

Authors:  Edwin O Onkendi; Sarah Y Boostrom; Michael G Sarr; Michael B Farnell; David M Nagorney; John H Donohue; Michael L Kendrick; Kaye M Reid-Lombardo; William S Harmsen; Florencia G Que
Journal:  J Gastrointest Surg       Date:  2012-02-17       Impact factor: 3.452

6.  The surgical treatment and outcome for primary duodenal adenocarcinoma.

Authors:  Shao-liang Han; Jun Cheng; Hong-zhong Zhou; Qi-Qiang Zeng; Sheng-Hong Lan
Journal:  J Gastrointest Cancer       Date:  2009-06-10

7.  Duodenal adenocarcinoma masked by acute cholecystitis and peptic ulcer disease.

Authors:  Manash R Sahoo; Manoj S Gowda
Journal:  BMJ Case Rep       Date:  2013-01-22

8.  The surgical treatment and outcome for primary duodenal adenocarcinoma.

Authors:  Shao-Liang Han; Jun Cheng; Hong-Zhong Zhou; Qi-Qiang Zeng; Sheng-Hong Lan
Journal:  J Gastrointest Cancer       Date:  2009-04-28

9.  Adenocarcinoma of the third and fourth portions of the duodenum: The capsule endoscopy value.

Authors:  Feliciano Chanana Paquissi; Ana Henriqueta Filipe Bunga Pimentel Lima; Maria de Fátima do Nascimento Vieira Lopes; Francisco Viamontes Diaz
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

10.  Prognostic factors associated with survival in patients with primary duodenal adenocarcinoma.

Authors:  Woo Chul Chung; Chang Nyol Paik; Sung Hoon Jung; Kang-Moon Lee; Sang Woo Kim; U-Im Chang; Jin Mo Yang
Journal:  Korean J Intern Med       Date:  2011-03-02       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.